Collegium Pharmaceutical (COLL) Acquisitions (2018 - 2022)
Collegium Pharmaceutical's (COLL) quarterly Acquisitions came in at $572.1 million in Q1 2022, up 493062.93% quarter-over-quarter from $116000.0 in Q2 2018.
Collegium Pharmaceutical (COLL) Acquisitions (2018 - 2022) Analysis & Trends
Collegium Pharmaceutical's Acquisitions history runs 2 years deep, the most recent figure standing at $572.1 million for Q1 2022.
- On a quarterly basis, Acquisitions changed N/A year-over-year to $572.1 million in Q1 2022; TTM through Dec 2022 was $572.1 million, a N/A change from a year earlier, with the FY2024 full-year figure at $267.5 million, changed N/A from the prior year.
- Acquisitions rose to $572.1 million in Q1 2022 per COLL's latest filing, from $116000.0 in the prior quarter.
- Across five years, Acquisitions topped out at $572.1 million in Q1 2022 and bottomed at $116000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Collegium Pharmaceutical | 1.14 Bn | 853.50 Mn | 117.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 572.07 Mn |
| Jun 30, 2018 | 116,000.00 |
| Mar 31, 2018 | 18.76 Mn |